189 related articles for article (PubMed ID: 7411865)
1. [A co-operative study on prophylaxis of fungal infection in patients with hematological diseases: prophylactic effect of oral administration of amphotericin B (author's transl)].
Suda T; Omine M; Tsuchiya J; Maekawa T; Muto Y; Mizoguchi H; Sakamoto S; Takaku F; Enokihara H; Saito K; Hirose K; Furusawa S; Shishido H
Rinsho Ketsueki; 1980 Feb; 21(2):195-9. PubMed ID: 7411865
[No Abstract] [Full Text] [Related]
2. [A co-operative study on prophylactic effect of oral administration of high-dose amphotericin B syrup for systemic fungal infection in patients with hematological neoplasms. Chugoku-Shikoku Study Group of Mycosis with Hematologic Disease].
Kimura I; Kuramoto J; Yahata Y; Irino S; Takahashi I; Sezaki T; Tsubota T; Watanabe Y; Hara M; Hino N
Gan To Kagaku Ryoho; 1990 May; 17(5):1027-32. PubMed ID: 2185693
[TBL] [Abstract][Full Text] [Related]
3. [The effect of oral high-dose amphotericin B in patients with acute leukemia: detection of fungi and prophylaxis for fungal infection].
Motomura S; Noguchi T; Kanamori H; Murata T; Harano H; Takahashi K; Matsuzaki M; Miyashita H; Ogawa K; Ito A
Rinsho Ketsueki; 1987 Nov; 28(11):1956-62. PubMed ID: 3446867
[No Abstract] [Full Text] [Related]
4. Prophylactic and therapeutic effects of oral administration of amphotericin B in mycosis associated with hematologic diseases. Study Group of Mycosis in Hematologic Disease.
Urabe A; Takaku F; Mizoguchi H; Nomura T; Ogawa T; Maekawa T; Omine M; Miura Y; Hirashima K; Takatani O
Jpn J Antibiot; 1990 Jan; 43(1):116-30. PubMed ID: 2190013
[TBL] [Abstract][Full Text] [Related]
5. [Tuberculosis in hematological diseases (author's transl)].
Yamauchi K; Matsumoto N; Fujita H; Oda S; Miwa S
Rinsho Ketsueki; 1979 Jun; 20(6):628-39. PubMed ID: 470156
[No Abstract] [Full Text] [Related]
6. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
Krick JA; Remington JS
Clin Haematol; 1976 Jun; 5(2):249-310. PubMed ID: 780028
[No Abstract] [Full Text] [Related]
8. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule.
Altmannsberger P; Holler E; Andreesen R; Krause SW
J Antimicrob Chemother; 2007 Jul; 60(1):180-2. PubMed ID: 17537868
[No Abstract] [Full Text] [Related]
10. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B
Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four hour continuous infusion of amphotericin B for the treatment of suspected or proven fungal infection in haematology patients.
Hall P; Kennedy G; Morton J; Hill GR; Durrant S
Intern Med J; 2005 Jun; 35(6):374. PubMed ID: 15892774
[No Abstract] [Full Text] [Related]
12. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Martino R; Nomdedéu J; Altés A; Sureda A; Brunet S; Martínez C; Domingo-Albós A
Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569
[TBL] [Abstract][Full Text] [Related]
13. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
Shah T; Lai WK; Gow P; Leeming J; Mutimer D
Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
[TBL] [Abstract][Full Text] [Related]
14. [Rheumatic-type manifestations in patients with malignant hemopathies].
Parasca I; Duţu A; Osman A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):369-75. PubMed ID: 2865799
[No Abstract] [Full Text] [Related]
15. Empiric amphotericin B therapy in patients with acute leukemia.
Holleran WM; Wilbur JR; DeGregorio MW
Rev Infect Dis; 1985; 7(5):619-24. PubMed ID: 3903941
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
Drugs Exp Clin Res; 1999; 25(4):193-200. PubMed ID: 10442277
[TBL] [Abstract][Full Text] [Related]
17. [Antimycotic prophylaxis with oral amphotericin B in patients with acute myeloid leukemia].
Orlandi E; Bernasconi C; Michelone G; Cavanna C; Lombardi G
Clin Ter; 1986 Sep; 118(6):427-31. PubMed ID: 3465492
[No Abstract] [Full Text] [Related]
18. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
19. Management of bacterial infections in haematological patients.
Galea G
Br J Hosp Med; 1982 Jul; 28(1):74, 76, 79 passim. PubMed ID: 6289951
[No Abstract] [Full Text] [Related]
20. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
